questionsmedicales.fr
Thérapeutique
Radiothérapie
Radiothérapie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Radiothérapie
Cancer
Diagnostic médical
Imagerie médicale
Radiothérapie
IRM
Oncologie
Radiothérapie
Médecin spécialiste
Cancer du sein
Cancer de la prostate
Radiothérapie
Radiothérapie
Prévention du cancer
Traitement du cancer
Symptômes
5
Effets secondaires
Radiothérapie
Symptômes
Nausées
Radiothérapie
Effets indésirables
Effets à long terme
Radiothérapie
Santé reproductive
Fatigue
Radiothérapie
Gestion des symptômes
Appétit
Radiothérapie
Effets secondaires
Prévention
5
Prévention du cancer
Radiothérapie
Traitement du cancer
Prévention du cancer
Mode de vie
Santé
Dépistage
Radiothérapie
Prévention du cancer
Vaccins
Prévention du cancer
HPV
Stress
Prévention du cancer
Santé mentale
Traitements
5
Radiothérapie externe
Curiethérapie
Radiothérapie
Chimiothérapie
Radiothérapie
Traitement combiné
Séances de traitement
Radiothérapie
Cancer
Douleur
Radiothérapie
Effets indésirables
Séance de radiothérapie
Radiothérapie
Procédure médicale
Complications
5
Complications
Radiothérapie
Effets indésirables
Cancers secondaires
Radiothérapie
Risques
Prévention
Complications
Suivi médical
Complications
Radiothérapie
Type de cancer
Soins post-traitement
Radiothérapie
Suivi médical
Facteurs de risque
5
Facteurs de risque
Cancer
Radiothérapie
Antécédents médicaux
Radiothérapie
Cancer
Sexe
Radiothérapie
Cancer
Alimentation
Facteurs de risque
Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Radiothérapie : Questions médicales les plus fréquentes",
"headline": "Radiothérapie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Radiothérapie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Radiothérapie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Curiethérapie",
"alternateName": "Brachytherapy",
"url": "https://questionsmedicales.fr/mesh/D001918",
"about": {
"@type": "MedicalCondition",
"name": "Curiethérapie",
"code": {
"@type": "MedicalCode",
"code": "D001918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimioradiothérapie",
"alternateName": "Chemoradiotherapy",
"url": "https://questionsmedicales.fr/mesh/D059248",
"about": {
"@type": "MedicalCondition",
"name": "Chimioradiothérapie",
"code": {
"@type": "MedicalCode",
"code": "D059248",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.160"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimioradiothérapie adjuvante",
"alternateName": "Chemoradiotherapy, Adjuvant",
"url": "https://questionsmedicales.fr/mesh/D059186",
"about": {
"@type": "MedicalCondition",
"name": "Chimioradiothérapie adjuvante",
"code": {
"@type": "MedicalCode",
"code": "D059186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.160.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation crânienne",
"alternateName": "Cranial Irradiation",
"url": "https://questionsmedicales.fr/mesh/D016371",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation crânienne",
"code": {
"@type": "MedicalCode",
"code": "D016371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.190"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Irradiation hypophysaire",
"alternateName": "Pituitary Irradiation",
"url": "https://questionsmedicales.fr/mesh/D010910",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation hypophysaire",
"code": {
"@type": "MedicalCode",
"code": "D010910",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.190.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation craniospinale",
"alternateName": "Craniospinal Irradiation",
"url": "https://questionsmedicales.fr/mesh/D061888",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation craniospinale",
"code": {
"@type": "MedicalCode",
"code": "D061888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.230"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie par ions lourds",
"alternateName": "Heavy Ion Radiotherapy",
"url": "https://questionsmedicales.fr/mesh/D063193",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie par ions lourds",
"code": {
"@type": "MedicalCode",
"code": "D063193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protonthérapie",
"alternateName": "Proton Therapy",
"url": "https://questionsmedicales.fr/mesh/D061766",
"about": {
"@type": "MedicalCondition",
"name": "Protonthérapie",
"code": {
"@type": "MedicalCode",
"code": "D061766",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.250.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation hémicorporelle",
"alternateName": "Hemibody Irradiation",
"url": "https://questionsmedicales.fr/mesh/D017619",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation hémicorporelle",
"code": {
"@type": "MedicalCode",
"code": "D017619",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.270"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Irradiation ganglionnaire",
"alternateName": "Lymphatic Irradiation",
"url": "https://questionsmedicales.fr/mesh/D015182",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation ganglionnaire",
"code": {
"@type": "MedicalCode",
"code": "D015182",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radioimmunothérapie",
"alternateName": "Radioimmunotherapy",
"url": "https://questionsmedicales.fr/mesh/D016499",
"about": {
"@type": "MedicalCondition",
"name": "Radioimmunothérapie",
"code": {
"@type": "MedicalCode",
"code": "D016499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.520"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie adjuvante",
"alternateName": "Radiotherapy, Adjuvant",
"url": "https://questionsmedicales.fr/mesh/D018714",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie adjuvante",
"code": {
"@type": "MedicalCode",
"code": "D018714",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dosimétrie en radiothérapie",
"alternateName": "Radiotherapy Dosage",
"url": "https://questionsmedicales.fr/mesh/D011879",
"about": {
"@type": "MedicalCondition",
"name": "Dosimétrie en radiothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011879",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fractionnement de la dose d'irradiation",
"alternateName": "Dose Fractionation, Radiation",
"url": "https://questionsmedicales.fr/mesh/D019583",
"about": {
"@type": "MedicalCondition",
"name": "Fractionnement de la dose d'irradiation",
"code": {
"@type": "MedicalCode",
"code": "D019583",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypofractionnement de dose",
"alternateName": "Radiation Dose Hypofractionation",
"url": "https://questionsmedicales.fr/mesh/D000069473",
"about": {
"@type": "MedicalCondition",
"name": "Hypofractionnement de dose",
"code": {
"@type": "MedicalCode",
"code": "D000069473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hypofractionnement de dose",
"alternateName": "Radiation Dose Hypofractionation",
"url": "https://questionsmedicales.fr/mesh/D000069473",
"about": {
"@type": "MedicalCondition",
"name": "Hypofractionnement de dose",
"code": {
"@type": "MedicalCode",
"code": "D000069473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie de haute énergie",
"alternateName": "Radiotherapy, High-Energy",
"url": "https://questionsmedicales.fr/mesh/D011882",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie de haute énergie",
"code": {
"@type": "MedicalCode",
"code": "D011882",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons",
"alternateName": "Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D017247",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons",
"code": {
"@type": "MedicalCode",
"code": "D017247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons par le bore",
"alternateName": "Boron Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D016754",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons par le bore",
"code": {
"@type": "MedicalCode",
"code": "D016754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons par le bore",
"alternateName": "Boron Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D016754",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons par le bore",
"code": {
"@type": "MedicalCode",
"code": "D016754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Télégammathérapie",
"alternateName": "Radioisotope Teletherapy",
"url": "https://questionsmedicales.fr/mesh/D011867",
"about": {
"@type": "MedicalCondition",
"name": "Télégammathérapie",
"code": {
"@type": "MedicalCode",
"code": "D011867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.820"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie guidée par l'image",
"alternateName": "Radiotherapy, Image-Guided",
"url": "https://questionsmedicales.fr/mesh/D061089",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie guidée par l'image",
"code": {
"@type": "MedicalCode",
"code": "D061089",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.768"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie X",
"alternateName": "X-Ray Therapy",
"url": "https://questionsmedicales.fr/mesh/D014964",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie X",
"code": {
"@type": "MedicalCode",
"code": "D014964",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.907"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie",
"alternateName": "Radiotherapy",
"code": {
"@type": "MedicalCode",
"code": "D011878",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David R Raleigh",
"url": "https://questionsmedicales.fr/author/David%20R%20Raleigh",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Baolin Qu",
"url": "https://questionsmedicales.fr/author/Baolin%20Qu",
"affiliation": {
"@type": "Organization",
"name": "Precision Medical Advanced Innovation Center, Beijing University of Aeronautics and Astronautics, Beijing, 100083."
}
},
{
"@type": "Person",
"name": "Gustavo Arruda Viani",
"url": "https://questionsmedicales.fr/author/Gustavo%20Arruda%20Viani",
"affiliation": {
"@type": "Organization",
"name": "Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil."
}
},
{
"@type": "Person",
"name": "P A Coucke",
"url": "https://questionsmedicales.fr/author/P%20A%20Coucke",
"affiliation": {
"@type": "Organization",
"name": "Service de Radiothérapie, CHU Liège, Belgique."
}
},
{
"@type": "Person",
"name": "William C Chen",
"url": "https://questionsmedicales.fr/author/William%20C%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Mild Photothermal Therapy Prevents Posterior Capsule Opacification through Cytoskeletal Remodeling.",
"datePublished": "2023-09-26",
"url": "https://questionsmedicales.fr/article/37728173",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/adhm.202300470"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effect of Nd:YAG Laser applied in the posterior capsule opacification on retinal and choroidal structures.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37295662",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pdpdt.2023.103653"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic accuracy of code-free deep learning for detection and evaluation of posterior capsule opacification.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/36161827",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjophth-2022-000992"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inhibition of anterior capsule opacification and contraction by the elevated anterior rim of the intraocular lens optic.",
"datePublished": "2023-08-03",
"url": "https://questionsmedicales.fr/article/37535105",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10384-023-01013-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Objective quantification of posterior capsule opacification after cataract surgery with swept-source optical coherence tomography.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37407917",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12886-023-03064-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Radiothérapie",
"item": "https://questionsmedicales.fr/mesh/D011878"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Radiothérapie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Radiothérapie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Radiothérapie",
"description": "Comment la radiothérapie est-elle diagnostiquée ?\nQuels examens précèdent la radiothérapie ?\nQui détermine le besoin de radiothérapie ?\nQuels types de cancers nécessitent la radiothérapie ?\nLa radiothérapie est-elle utilisée en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Capsule+Opacification#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Radiothérapie",
"description": "Quels symptômes peuvent apparaître après la radiothérapie ?\nLa radiothérapie cause-t-elle des nausées ?\nY a-t-il des symptômes à long terme ?\nComment gérer la fatigue liée à la radiothérapie ?\nLa radiothérapie affecte-t-elle l'appétit ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Capsule+Opacification#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Radiothérapie",
"description": "La radiothérapie peut-elle prévenir le cancer ?\nQuels modes de vie aident à prévenir le cancer ?\nLes dépistages aident-ils à éviter la radiothérapie ?\nLes vaccins peuvent-ils prévenir certains cancers ?\nLe stress influence-t-il le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Capsule+Opacification#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Radiothérapie",
"description": "Quels types de radiothérapie existent ?\nLa radiothérapie est-elle combinée à d'autres traitements ?\nCombien de séances de radiothérapie sont nécessaires ?\nLa radiothérapie est-elle douloureuse ?\nComment se déroule une séance de radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Capsule+Opacification#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Radiothérapie",
"description": "Quelles sont les complications possibles de la radiothérapie ?\nLa radiothérapie peut-elle causer des cancers secondaires ?\nComment prévenir les complications de la radiothérapie ?\nLes complications varient-elles selon le type de cancer ?\nQuels soins sont nécessaires après la radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Capsule+Opacification#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Radiothérapie",
"description": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?\nL'âge influence-t-il le besoin de radiothérapie ?\nLes antécédents médicaux influencent-ils la radiothérapie ?\nLe sexe joue-t-il un rôle dans le traitement par radiothérapie ?\nL'alimentation affecte-t-elle le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Capsule+Opacification#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la radiothérapie est-elle diagnostiquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie n'est pas diagnostiquée, mais elle est prescrite après un diagnostic de cancer."
}
},
{
"@type": "Question",
"name": "Quels examens précèdent la radiothérapie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme le scanner ou l'IRM sont souvent réalisés avant la radiothérapie."
}
},
{
"@type": "Question",
"name": "Qui détermine le besoin de radiothérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un oncologue est responsable de l'évaluation et de la prescription de la radiothérapie."
}
},
{
"@type": "Question",
"name": "Quels types de cancers nécessitent la radiothérapie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est couramment utilisée pour les cancers du sein, de la prostate et du poumon."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée en prévention ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie est un traitement curatif, pas préventif, pour les cancers diagnostiqués."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après la radiothérapie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, rougeur de la peau et douleurs localisées selon la zone traitée."
}
},
{
"@type": "Question",
"name": "La radiothérapie cause-t-elle des nausées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées peuvent survenir, surtout si la zone traitée est l'abdomen ou le cerveau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes à long terme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme peuvent inclure des changements cutanés ou des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment gérer la fatigue liée à la radiothérapie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de se reposer, de bien s'hydrater et de suivre les conseils du médecin."
}
},
{
"@type": "Question",
"name": "La radiothérapie affecte-t-elle l'appétit ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent éprouver une perte d'appétit pendant le traitement."
}
},
{
"@type": "Question",
"name": "La radiothérapie peut-elle prévenir le cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie est un traitement, pas un moyen de prévention du cancer."
}
},
{
"@type": "Question",
"name": "Quels modes de vie aident à prévenir le cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et l'évitement du tabac peuvent aider à prévenir le cancer."
}
},
{
"@type": "Question",
"name": "Les dépistages aident-ils à éviter la radiothérapie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent détecter le cancer tôt, réduisant ainsi le besoin de radiothérapie."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir certains cancers ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vaccins comme celui contre le HPV peuvent prévenir certains cancers, comme le cancer du col de l'utérus."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il le cancer ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress n'est pas un facteur direct, mais un mode de vie sain peut aider à réduire le risque."
}
},
{
"@type": "Question",
"name": "Quels types de radiothérapie existent ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux types sont la radiothérapie externe et la radiothérapie interne (curiethérapie)."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle combinée à d'autres traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec la chimiothérapie ou la chirurgie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Combien de séances de radiothérapie sont nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie selon le type de cancer, généralement entre 5 et 30 séances."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle douloureuse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie elle-même n'est pas douloureuse, mais des effets secondaires peuvent l'être."
}
},
{
"@type": "Question",
"name": "Comment se déroule une séance de radiothérapie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le patient est positionné sur une table, et des rayons ciblés sont administrés sans douleur."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la radiothérapie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des lésions tissulaires, des infections et des effets secondaires à long terme."
}
},
{
"@type": "Question",
"name": "La radiothérapie peut-elle causer des cancers secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque faible de développer des cancers secondaires après une radiothérapie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications de la radiothérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et le respect des recommandations du médecin aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier selon la localisation et le type de cancer traité."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires après la radiothérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de la peau, une bonne hydratation et un suivi médical sont essentiels après le traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition à des substances cancérigènes et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le besoin de radiothérapie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cancer augmente avec l'âge, ce qui peut nécessiter une radiothérapie."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la radiothérapie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer ou de radiothérapie peuvent influencer le traitement futur."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le traitement par radiothérapie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines cancers sont plus fréquents chez un sexe, influençant ainsi le besoin de radiothérapie."
}
},
{
"@type": "Question",
"name": "L'alimentation affecte-t-elle le risque de cancer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu.
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Precision Medical Advanced Innovation Center, Beijing University of Aeronautics and Astronautics, Beijing, 100083.
Department of Radiotherapy, PLA General Hospital, Beijing, 100853.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Service de Radiothérapie, CHU Liège, Belgique.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu.
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Johns Hopkins University, Baltimore, MD, 21287, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, Ohio State University, Columbus, OH, 43210, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Neurological Surgery, Northwestern University, Chicago, IL, 60611, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Jiangsu 404100, China.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Münster, Gebäude A1, Albert Schweitzer Campus, 48149, Münster, Deutschland. hans.eich@ukmuenster.de.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, The Mayo Clinic, Rochester, MN, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
University Hospital for Tumors, Sestre milosrdnice University Hospital Center.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA 90095, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Dept. of Radiation Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Liver Surgery and Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, Sichuan University and Collaborative Innovation Center of Biotherapy, West China Hospital, Chengdu, Sichuan 610000, P.R. China.
Publications dans "Radiothérapie" :
Cataract is the first leading cause of blindness in the world and posterior capsule opacification (PCO) is the most common long-term complication after surgery. The primary pathogenic processes contri...
To assess the effect of neodymium:yttrium-aluminum-garnet (Nd-YAG) laser procedure on the choroid and retina in patients who developed posterior capsular opacification (PCO) after cataract surgery....
In this study, 32 eyes of 30 patients who underwent Nd:YAG laser treatment for PCO were evaluated. Visual acuity (VA), intraocular pressure (IOP), central macular thickness (CMT) with optical coherenc...
The mean age of the patients participating in the study was 60.1 ± 8.9 years. There was no significant difference in IOP, CMT, RNFL, GCL, IPL and SCT values in all comparisons before and after laser...
CVI was found to be significantly higher in the post-laser period in patients who underwent Nd:YAG laser. As far as the author knows, this study is the first research in the literature to evaluate thi...
To train and validate a code-free deep learning system (CFDLS) on classifying high-resolution digital retroillumination images of posterior capsule opacification (PCO) and to discriminate between clin...
For this retrospective registry study, three expert observers graded two independent datasets of 279 images three separate times with no PCO to severe PCO, providing binary labels for clinical signifi...
Intraobserver variability κ values for observers 1, 2 and 3 were 0.90 (95% CI 0.86 to 0.95), 0.94 (95% CI 0.90 to 0.97) and 0.88 (95% CI 0.82 to 0.93). Interobserver agreement was high, ranging from 0...
This CFDLS provides highly accurate discrimination between clinically significant and non-significant PCO equivalent to human expert graders. The clinical value as a potential decision support tool in...
To verify the anterior capsule opacification (ACO) and contraction (ACC) of the ZCB00V intraocular lens (IOL), made of the same material as the AR40e with a high ACC rate....
Retrospective cohort study....
We evaluated 35 patients at 1 week, 1, 3 and 6 months post phacoemulsification with either a ZCB00V (n = 35) or FY-60AD (n = 34) IOL implantation. The ACC rate was calculated using retroillumination i...
The postoperative ACC rates (mean ± standard deviation) at 3 months were 1.03%±2.54% for the ZCB00V and, and 7.12%±9.47% for the FY-60AD. The ZCB00V-implanted eyes showed a significantly lower postope...
The ACC and ACO were significantly lower in eyes with ZCB00V IOLs compared to those with the FY-60AD. The anterior segment image analysis revealed that the elevated anterior rim of the ZCB00V IOL prev...
To evaluate the application of swept-source optical coherence tomography (SS-OCT) and pentacam scheimpflug tomography in posterior capsule opacification (PCO) severity assessment....
The posterior capsule image region segmentation and adaptive threshold algorithm are used to process the SS-OCT scanned image to obtain the posterior capsule thickness (PCT). Scheimpflug tomography re...
One hundred sixty-two IOL eyes of 101 patients were divided into two groups, laser group (65 eyes) with the mean PCT was 8.0 ± 2.7 pixel unit and the mean gray value of the eyes was 66 ± 33 pixel unit...
The region segmentation and adaptive threshold algorithm of posterior capsule image will accurately quantify the posterior capsule. Computer aided quantifications of posterior capsule are of great sig...
To evaluate the long-term posterior capsule opacification (PCO) formation, and glistening rate of the HOYA Vivinex (XY1) IOL compared to Alcon AcrySof (SN60WF). In this prospective, multicentric, rand...
Posterior Capsule Opacification (PCO) is the most common long-term post-operative adverse occurrence after cataract surgery often requiring treatment with YAG laser posterior capsulotomy. This study a...
A retrospective study of publicly funded cataract surgery from The Royal College of Ophthalmologists' National Ophthalmology Database. Eligible for analysis were 500,872 cataract operations performed ...
The 500,872 operations were performed on 243,167 (48.5%) left eyes and 257,705 (51.5%) right eyes from 373,579 patients by 2196 surgeons. Post-cataract PCO was recorded for 61,778 (12.3%) eyes and the...
Many factors influence the development of PCO relating to the patient, the eye, the lens and the surgery. Some factors are modifiable such as IOL material, therefore the opportunity exists to attempt ...
To study the viability of visual simulation of presbyopic correction in patients with cataract and the effect and impact of the cataract on the perceived visual quality of the different simulated pres...
San Carlos Clinical Hospital, Madrid, Spain....
Observational, noninterventional, pilot study, early feasibility of the device being studied....
Cataract patients were tested preoperatively (n = 24) and postoperatively (n = 15) after bilateral implantation of monofocal intraocular lenses (IOLs). The degree of cataract was evaluated objectively...
VA was significantly correlated with OSI ( r = -0.71, P < .0005), although the visual degradation at far for each correction was constant and not correlated with OSI. The visual benefit at near distan...
Visual simulations of IOLs are an excellent tool to explore prospective postoperative vision. The high correlation in the perceptual scores pre- and post-cataract surgery demonstrates that SimVis Gekk...
To report the prevalence of late postoperative opacification of a hydrophilic and hydrophobic acrylic intraocular lens (IOL) and to assess the risk factors in a subset of 212 eyes of patients referred...
Retrospective case series....
A survey was performed at all large ophthalmological clinics in Switzerland regarding exchanged Lentis LS-502-1 lenses, and the number of affected eyes was counted. Moreover, consecutive patients who ...
A total of 674 opacified Lentis LS-502-1 lenses have been reported in Switzerland, and 212 consecutive eyes of 182 patients were included in the study. All IOLs had a similar pattern of opacification ...
The prevalence of IOL opacification was 9.9%. No associated systemic eye disease or medications could be detected, which was implicated in the opacification process. The reason for opacification remai...
Posterior capsule opacification (PCO) is a common postoperative complication of extracapsular cataract surgery, which is caused by the proliferation and migration of lens epithelial cells and can affe...